Nemera designs, develops, and manufactures a full range of complex drug delivery devices including auto-injectors, pens, inhalers, preservative-free multi-dose eye droppers and pumps from seven state-of-the-art manufacturing sites in France, the US, Germany, Poland and Brazil. The Company serves a global base of pharmaceutical, biotech, and generics customers, providing end-to-end solutions from early-stage design to large-scale manufacturing, across both proprietary devices and contract manufacturing. Its patient-focused approach and breadth of expertise enable Nemera to deliver innovative, reliable, and safe devices that improve treatment outcomes and patient experience.
With the support of Montagu and Astorg, Nemera has grown in both scale and strategic value over the past six years. With continued support from its existing shareholders and the addition of LGT CP, Nemera is well positioned to accelerate its growth trajectory. The Company will continue to invest in innovation, operational excellence, and capacity expansion to meet growing demand across all therapeutic areas. Strategic priorities include strengthening its proprietary product portfolio, expanding global manufacturing capabilities, and further developing its service offerings.
Heloise Pujolle, Partner at Montagu, said: "We are delighted to welcome LGT CP as a shareholder in Nemera. Since our re-investment in 2019, Nemera has delivered strong growth, broadened its global footprint, and reinforced its market leadership. This transaction demonstrates our continued confidence in the Company’s strategy and management team, and we look forward to partnering with LGT CP, alongside Astorg, to support Nemera in its next phase of development."
Nicolas Marien, Partner at Astorg, said: “Over the course of our partnership, Nemera has grown significantly, expanded its customer base and strengthened its position in the most attractive drug delivery segments, supported by a stronger innovation pipeline and a truly global footprint. We’re proud of what we’ve achieved with Nemera’s management team and Montagu, and look forward to partnering with LGT CP to further accelerate growth and create lasting value.”
Andreas Hellmann, Partner at LGT Capital Partners, said: "We are pleased to join Nemera as a minority investor at an important stage in its growth journey. Having followed the Company over a number of years, we appreciate its effective leadership, commitment to innovation, and focus on improving patients’ lives – qualities that position Nemera as a leader in the drug delivery space. We look forward to supporting the management team and existing shareholders, Montagu and Astorg, as the Company continues to scale globally and provide advanced solutions to its partners and patients worldwide."
Astorg and Montagu were advised by Morgan Stanley (Financial advisors), and Weil Gotshal & Manges (Legal advisor)
Astorg
Astorg is a leading pan-European private equity firm with over €23 billion of assets under management. Astorg works with entrepreneurs and management teams to acquire market leading international companies headquartered in Europe or the US, providing them with the strategic guidance, governance and capital they need to achieve their growth goals. Enjoying a distinct entrepreneurial culture, a long-term shareholder perspective and a lean decision making body, Astorg has valuable industry expertise in healthcare, technology & software, and business services companies. Headquartered in Luxembourg, Astorg has offices in London, Paris, New York, Frankfurt and Milan. For more information about Astorg: www.astorg.com | Follow Astorg on LinkedIn.
Montagu
Montagu is a leading mid-market private equity firm, committed to finding and growing businesses that make the world work. Focussing on businesses with a must-have product or service in a structurally growing marketplace, Montagu brings proven growth capabilities to help companies achieve their ambitions and unlock their full potential. Montagu specialises in carve-out and other first time buyout investments and has deep expertise in five priority sectors: Healthcare, Financial Sector Services, Critical Data, Digital Infrastructure and Education. ESG forms an integral part of its strategy, and its commitment to responsible investment is fully integrated into its investment and value-creation process.
For additional information on Montagu, visit www.montagu.com
LGT Capital Partners
LGT Capital Partners is a leading global specialist in alternative investing with over USD 100 billion in assets under management and more than 700 institutional clients in 50 countries. An international team of over 900 professionals is responsible for managing a wide range of investment programs focusing on private markets, multi-alternatives and diversifying strategies, as well as sustainable and impact strategies. Headquartered in Pfaeffikon (SZ), Switzerland, the firm has offices in San Francisco, New York, Dublin, London, Paris, The Hague, Luxembourg, Frankfurt am Main, Vaduz, Dubai, Beijing, Hong Kong, Tokyo, Singapore and Sydney.